YPSOMED AG
About Ypsomed
Ypsomed is the leading developer and manufacturer of injection systems for the self-administration of liquid injectable medications. As the reliable partner of pharmaceutical and biotech companies for more than 40 years, Ypsomed provides tailored selfcare solutions to meet specific needs. Backed by a proven track record, Ypsomed offers the most comprehensive and innovative platform portfolio for pens, autoinjectors, and on-body devices. Delivered with best-in-class execution and ready to integrate with digital health services, these solutions help simplify therapy and improve the quality of life for millions of people living with chronic conditions. Ypsomed is headquartered in Burgdorf, Switzerland, and operates a global network of manufacturing facilities. More than 2,000 employees worldwide are committed every day to making selfcare simpler and easier.
CATEGORIES
Reto Jost, Nadine Kaufmann and Shawn James discuss three complementary decision lenses and explain how they offer a practical framework for...
Could a groundbreaking new regulatory framework transform clinical device bridging? Discover what the EMA-qualified MIDBA approach means for...
Ypsomed has received another industry award for its YpsoLoop autoinjector. At the Pharmapack Awards 2026, YpsoLoop won in the category...
Ypsomed is expanding its clinical excellence offering to support faster and more reliable clinical trials for subcutaneous injectable drugs....
